Simple diagnosis ofSTAT1gain-of-function alleles in patients with chronic mucocutaneous candidiasis
- 16 December 2013
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 95 (4) , 667-676
Abstract
CMCD is a rare congenital disorder characterized by persistent or recurrent skin, nail, and mucosal membrane infections caused by Candida albicans. Heterozygous GOF STAT1 mutations have been shown to confer AD CMCD as a result of impaired dephosphorylation of STAT1. We aimed to identify and characterize STAT1 mutations in CMCD patients and to develop a simple diagnostic assay of CMCD. Genetic analysis of STAT1 was performed in patients and their relatives. The mutations identified were characterized by immunoblot and reporter assay using transient gene expression experiments. Patients' leukocytes are investigated by flow cytometry and immunoblot. Six GOF mutations were identified, three of which are reported for the first time, that affect the CCD and DBD of STAT1 in two sporadic and four multiplex cases in 10 CMCD patients from Japan. Two of the 10 patients presented with clinical symptoms atypical to CMCD, including other fungal and viral infections, and three patients developed bronchiectasis. Immunoblot analyses of patients' leukocytes showed abnormally high levels of pSTAT1 following IFN-γ stimulation. Based on this finding, we performed a flow cytometry-based functional analysis of STAT1 GOF alleles using IFN-γ stimulation and the tyrosine kinase inhibitor, staurosporine. The higher levels of pSTAT1 observed in primary CD14+ cells from patients compared with control cells persisted and were amplified by the presence of staurosporine. We developed a flow cytometry-based STAT1 functional screening method that would greatly facilitate the diagnosis of CMCD patients with GOF STAT1 mutations.Keywords
Funding Information
- Japan Society for the Promotion of Science (22591161)
- Research on Measures for Intractable Diseases
- Japanese Ministry of Health, Labor and Welfare (H22-Nanchi-ippan-078)
- The Rockefeller University
- National Center for Research Resources
- National Center for Advancing Sciences
- U.S. National Institutes of Health (8UL1TR000043)
- St. Giles Foundation
- AXA Research Fund
- Stony Wold-Herbert Fund
- Analysis Center of Life Science, Natural Science Center for Basic Research and Development, Hiroshima University
This publication has 44 references indexed in Scilit:
- Adjunctive interferon-γ immunotherapy for the treatment of HIV-associated cryptococcal meningitisAIDS, 2012
- Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasisJournal of Experimental Medicine, 2011
- Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 ImmunityScience, 2011
- Revisiting Human IL-12Rβ1 DeficiencyMedicine, 2010
- Autoantibodies against IL-17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type IJournal of Experimental Medicine, 2010
- Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17-associated cytokinesJournal of Experimental Medicine, 2010
- Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndromeJournal of Experimental Medicine, 2009
- Mutations in STAT3 and IL12RB1 impair the development of human IL-17–producing T cellsJournal of Experimental Medicine, 2008
- Deficiency of Th17 cells in hyper IgE syndrome due to mutations in STAT3 Journal of Experimental Medicine, 2008
- Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndromeNature, 2008